Matches in Wikidata for { <http://www.wikidata.org/entity/Q66030339> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q66030339 description "clinical trial" @default.
- Q66030339 description "ensayu clínicu" @default.
- Q66030339 description "klinisch onderzoek" @default.
- Q66030339 description "клінічне випробування" @default.
- Q66030339 name "Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors" @default.
- Q66030339 name "Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors" @default.
- Q66030339 type Item @default.
- Q66030339 label "Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors" @default.
- Q66030339 label "Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors" @default.
- Q66030339 prefLabel "Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors" @default.
- Q66030339 prefLabel "Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors" @default.
- Q66030339 P1050 Q66030339-838FA6DC-4CCC-4278-899F-F3E9172E2E12 @default.
- Q66030339 P1050 Q66030339-8D90144A-54C0-4B79-B76F-16885634EC66 @default.
- Q66030339 P1050 Q66030339-ABD12004-711C-454A-AF7B-99F1211080B2 @default.
- Q66030339 P1050 Q66030339-CEFF3762-4B1E-4D66-BF94-6BB818768CCA @default.
- Q66030339 P1050 Q66030339-DB0F2318-6D85-4E4B-85E4-818CF1A64E25 @default.
- Q66030339 P1132 Q66030339-D628D03A-7AFF-4D62-B8CB-0924A8410B62 @default.
- Q66030339 P1476 Q66030339-CAF9E1B7-5082-4C7C-9808-4A86A16F24FF @default.
- Q66030339 P17 Q66030339-3310632F-F099-488A-A917-83BEE3FEF212 @default.
- Q66030339 P2899 Q66030339-02A18729-41B7-4A96-A515-4D6A7F895738 @default.
- Q66030339 P3098 Q66030339-F0641D00-4203-4AA4-856C-6E40252923E6 @default.
- Q66030339 P31 Q66030339-57926816-DF03-4F16-BDEA-400DC99C337E @default.
- Q66030339 P580 Q66030339-AC242EBF-E61B-4D20-81E2-2CD9EBA2E769 @default.
- Q66030339 P582 Q66030339-CA5F8DC2-0EEB-42D4-98B0-D3F212D2AB80 @default.
- Q66030339 P6099 Q66030339-028DA0B5-22C6-4773-B3B7-7E5B6C2F5E61 @default.
- Q66030339 P6153 Q66030339-FCD7A035-467F-4700-A482-CAA5B97C5C65 @default.
- Q66030339 P8363 Q66030339-36FAA869-6041-484D-B2A8-C7A77F222DCA @default.
- Q66030339 P1050 Q1501239 @default.
- Q66030339 P1050 Q1518637 @default.
- Q66030339 P1050 Q1736456 @default.
- Q66030339 P1050 Q770843 @default.
- Q66030339 P1050 Q786852 @default.
- Q66030339 P1132 "+93" @default.
- Q66030339 P1476 "A Phase II Trial of Bay 43-9006 in Progressive Metastatic Neuroendocrine Tumors" @default.
- Q66030339 P17 Q30 @default.
- Q66030339 P2899 "+18" @default.
- Q66030339 P3098 "NCT00131911" @default.
- Q66030339 P31 Q30612 @default.
- Q66030339 P580 "2005-06-01T00:00:00Z" @default.
- Q66030339 P582 "2010-10-01T00:00:00Z" @default.
- Q66030339 P6099 Q42824440 @default.
- Q66030339 P6153 Q1130172 @default.
- Q66030339 P8363 Q78089383 @default.